mGluR5 (amyloid-beta oligomer receptor)

Class

mGluR5-modulating amyloid-beta oligomer receptor inhibitor

Metabotropic glutamate receptor 5 (mGluR5) is a G-protein-coupled receptor expressed on neurons that normally responds to the neurotransmitter glutamate, helping regulate synaptic signaling and plasticity, the cellular basis of learning and memory. In Alzheimer's disease research, mGluR5 has been identified as a co-receptor: small, soluble clusters of amyloid-beta protein (oligomers), rather than acting alone, dock onto a cell-surface protein called cellular prion protein, and this complex recruits mGluR5 to relay a toxic intracellular signal. This signaling cascade is thought to contribute to synaptic dysfunction, impaired signaling at nerve connections, and downstream processes linked to tau pathology, another hallmark of the disease. The rationale for targeting mGluR5 in this context is not to block its everyday glutamate-driven function, which is essential for normal cognition, but to selectively interrupt the receptor's participation in this amyloid-beta-triggered toxic complex. Compounds designed for this purpose act as allosteric modulators, binding a site distinct from where glutamate binds, allowing them to disrupt the pathological interaction while leaving ordinary receptor signaling largely intact. This approach broadly matters for neurodegenerative disease strategies that aim to interrupt amyloid-beta toxicity at the level of neuronal signaling rather than by simply reducing amyloid burden itself.